Drawing from her life's journey and from ancient Indian scriptures, Uma Saini offered five simple lessons, from developing a positive attitude to living in unity, to the 2005 graduating class in her baccalaureate address before Commencement ceremonies on Sunday morning, May 29.
Mixing traditional graduation sentiments with a smattering of politics, former NATO Supreme Allied Commander Gen. Wesley Clark got Cornell's Commencement Weekend off to a rousing start with a Senior Convocation address in which he invited the graduates to assume leadership roles in the "community of American citizens" and, incidentally, to lead the country in a different direction than the one it's now pursuing.
Gen. Wesley Clark, a 2004 Democratic Party presidential primary candidate, doesn't rule out a continued political future for himself, reiterating his anthem of being "a strong supporter of a two-party system." The four-star general was speaking at a press conference at Cornell University's three-star Statler Hotel, prior to his May 28 Senior Convocation address.
When the black cloth came down and the dinner crowd at Duffield Hall got its first look at Hunter Rawlings' official presidential portrait, Cornell's 10th president, who stepped down in 2003, was pleased and gracious. But surprised?
The Cornell community continues to be a welcoming place for women and minorities, Robert Harris, vice provost for diversity and faculty development, told the Cornell Board of Trustees on May 27. Other universities may be getting more press for increasing attention on diversity, Harris said, but Cornell's hiring and enrollment statistics show a consistent, positive trend toward attracting and retaining a diverse workforce and student body.
Following the recent deadly outbreak of equine herpes virus at Churchill Downs, home of the Kentucky Derby, a Cornell University virologist says his preliminary research indicates that vaccines containing weakened live viruses, called modified live vaccines (MLV), appear to be more effective in preventing horse herpes than other more widely used vaccines.
One of the dreams of both science fiction writers and practical robot builders has been realized, at least on a simple level: Cornell University researchers have created a machine that can build copies of itself.
Cornell's Merrill Presidential Scholars Program honored 37 Cornell undergraduate students this week, while also honoring the high school teachers and university faculty members who made important contributions to the students' lives.
NEW YORK -- Shahin Rafii, an internationally acclaimed cancer and vascular biologist and stem cell authority at Weill Cornell Medical College (WCMC), has been named one of 43 new investigators by the Howard Hughes Medical Institute (HHMI). The honor is bestowed annually on the nation's most promising and gifted biomedical scientists.
NEW YORK -- Last fall two students at Weill Cornell Medical College -- Brant W. Ullery '08 and Avnish Deobhakta '08 -- founded the Medical Students for the Advancement of Transplantation (MSAT) to raise awareness about organ donation for medical students and the public alike, and to build a support system among organ donors and recipients. At the inaugural meeting May 5, the students invited Rob Kochik, clinical director of the New York Organ Donor Network, to describe scenarios in which organ donation could save a life.
Students at the Cornell Graduate School of Medical Sciences received their first taste of professional life at the Vincent du Vigneaud Symposium, May 3, 2005. Every year since 1981, the symposium has devoted a day for students to present their research in front of colleagues and faculty. The symposium honors the Nobel laureate and head of the Department of Biochemistry at the medical college from 1938 to 1967.
NEW YORK (May 23, 2005) -- A biochemical partnership between two novel compounds called cell-cycle inhibitors is crucial to the development of blood vessels that help tumors survive and thrive, according to a collaborative Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Center study just published in the Proceedings of the National Academy of Sciences.When researchers transplanted tumors into mice genetically engineered to lack two of these inhibitors, those tumors failed to develop much-needed vasculature -- a process called angiogenesis.
